1 / 23

Is There a Better or a Best Opioid?

Is There a Better or a Best Opioid?. S. Lawrence Librach MD,CCFP,FCFP Professor, Family & Community Medicine Sun Life Financial Chair in Bioethics. The Simple Answer. It depends!. Pharmacogenetics & Role in Opioid Selection.

schuyler
Download Presentation

Is There a Better or a Best Opioid?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Is There a Better or a Best Opioid? S. Lawrence Librach MD,CCFP,FCFP Professor, Family & Community Medicine Sun Life Financial Chair in Bioethics

  2. The Simple Answer It depends!

  3. Pharmacogenetics & Role in Opioid Selection • Increasing evidence that perception of pain & response to analgesics especially opioids have genetic components • Pain thresholds & processing • Drug pharmacokinetics & pharmacodynamics • Single nucleotide polymorphism in a number of genes may be responsible for individual variation

  4. Pharmacogenetics & Role in Opioid Pharmacokinetics • Metabolism of opioids mostly dependent on 2 pathways • Cytochrome P450 2D6 & 3A enzymes (CYT) • Uridine-diphosphoglucuronosyltransferase (UGT) • e.g. codeine • Ultrarapid metabolizers in children responsible for caution re: use in children • Poor metabolizers have functionally impaired CYP2D6 (7-10% Caucasians, 3% Blacks, 1% Asians)limited effect because cannot convert to morphine

  5. Pharmacogenetics & Role in Opioid Receptors • Opioid receptorsmu, delta, kappa & “orphan receptor” ORL 1 have all been found to have genetic variants • For mu receptors • Different binding to receptors • Receptor density, location, dimers • Addiction • Require more opioid for same effect • No clear info re: impact on or receptors

  6. Pharmacogenetics & Multidrug Resistance-1 Gene (MDR-1) • MDR-1 limits GI absorption & excretion via liver, kidneys or GI tract • Certain genotypes associated with increased adverse effects • ORLs associated with better response

  7. Pharmacogenetic Testing • The next horizon • As genome testing becomes less expensive may be a factor in the future

  8. Opioid Metabolism • Clearance of metabolites an issue with morphine, hydromorphone, oxycodone as metabolites can build up in renal failure • Hepatic failure requires adjustment of all opioids

  9. Opioid Pharmacokinetics

  10. Lipid Solubility of Some CommonOpioid Drugs DRUG HEPTANE - BUFFER PARTITION COEFFICIENT • Morphine • Hydromorphone • Fentanyl • Methadone • 000001 • 00001 • 196 • 446

  11. Opioids Tolerance & Hyperalgesia • Experience with chronic administration of opioids in cancer or other illnesses has shown us that analgesia is not always maintained • OT defined as reduction in response to same dose of opioid after repeated exposure or when  doses required to achieve same effect

  12. Opioids & Tolerance • Clearly seen in animal models fairly early on • Clinical trials are difficult to do especially in cancer pain • Certain effects of opioids like respiratory depression, nausea, sedation are often tolerated quickly but analgesic tolerance may not be seen or diagnosed

  13. Opioid Tolerance & Clinical Relevance • Not clear but some interesting possibilities to consider • If pain is  even in presence of disease , need to consider tolerance • May justify opioid rotation more frequently • Should every patient we treat have a cocktail of opioids plus co-analgesics? • Need studies

  14. Poor Choices for Opioids • Pethidine (meperidine) • Poor oral absorption • Metabolite toxicity • Pentazocine • Dextropropoxyphene • Tramadol • For severe pain

  15. Pain Severity • Start with strong opioids in moderate to severe pain • Little to gain by starting with weak drugs

  16. Type of Pain • All opioids effective in neuropathic pain • Methadone may have an advantage • All opioids similarly effective in inflammatory (nociceptive pain)

  17. Adverse Effects • No evidence that any opioid better than another for adverse effects • However, some patients report differences

  18. Physician Factors • Experience • “my favourite opioid is…..” • Fear or ignorance

  19. Opioid Availability • Menu should be full of choices

  20. Dr. Larry Librach Temmy Latner Centre for Palliative Care 20

  21. Costs • Sustained release drugs may not be necessary • Affordability for patients • Affordability for the system • e.g. transmucosal fentanyl products

  22. Special Issues • Drug interactions • Additive effects • CYP 450 inhibition • e.g. tramadol, methadone, fentanyl • Universal precautions for opioids

  23. Summary • Really is no one best opioid • Need more than morphine in your formulary as tolerance may be an issue

More Related